Groups | n | Substance | Description |
---|---|---|---|
I | 6 | Normal control | Only fodder and water. |
II | 6 | Sham control | Tibial and Sural nerve exposed without any transaction. |
III | 6 | TST | TST were performed. |
IV | 6 | Vehicle in TST | CMC 0.5%Â w/v, p. o. was administered for 24Â days daily. |
V | 6 | PFE per se | PFE (300Â mg/kg p. o. ones daily) was administered to the normal rats for 24 consecutive days. |
VI&VII | 6 | PFE + TST | PFE (100 and 300 mg/kg p. o. respectively) were administered to the TST rats for 24 consecutive days |
VIII | 6 | BADGE (PPAR-γ antagonist) + TST | BADGE was administered (120 mg/kg IP) to the TST rats for 24 consecutive days. |
IX & X | 6 | BADGE + PFE + TST | BADGE was administered (120 mg/kg IP) before PFE (100 and 300 mg/kg p. o. respectively) administration to the TST rats for 24 consecutive days. |
XI | 6 | L-NAME + TST | L-NAME was administered (5 mg/kg IP) to the TST rats for 24 consecutive days. |
XII | 6 | L-arginine + TST | L-arginine was administered (100 mg/kg IP) to the TST rats for 24 consecutive days. |
XIII & XIV | 6 | L-NAME + PFE + TST | L-NAME was administered (5 mg/kg IP) before PFE (100 and 300 mg/kg p. o. respectively) administration to the TST rats for 24 consecutive days. |
XV & XVI | 6 | L-arginine + PFE + TST | L-arginine was administered (100 mg/kg IP) before PFE (100 and 300 mg/kg p. o. respectively) administration to the TST rats for 24 consecutive days. |
XVII | 6 | Gabapentin per se | Gabapentin (100Â mg/kg) p. o. administration to the normal rats for 24 consecutive days. |
XVIII | 6 | Gabapentin + TST | Gabapentin (100 mg/kg) p. o. administration to the TST rats for 24 consecutive days. |